Societal CDMO Inc (NAS:SCTL)
$ 1.1 0.01 (0.92%) Market Cap: 121.61 Mil Enterprise Value: 155.86 Mil PE Ratio: 0 PB Ratio: 1.97 GF Score: 32/100

Q2 2019 Recro Pharma Inc Earnings Call Transcript

Aug 08, 2019 / 12:00PM GMT
Release Date Price: $9.74 (+11.44%)
Operator

Good morning, and welcome to the Recro Pharma Second Quarter's 2019 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded at the company's request.

I would now like to turn the call over to Claudia Styslinger, Investor Relations. You may begin.

Claudia Styslinger
Argot Partners, LLC - IR Associate

Good morning, and thank you for joining us on today's conference call to discuss Recro's Second Quarter 2019 Financial Results. This is Claudia Styslinger, and I'm joined today by Gerri Henwood, President and Chief Executive Officer; and Ryan Lake, Chief Financial Officer. Following prepared remarks today by Gerri and Ryan, we will open the call for questions.

Earlier this morning, we issued a press release detailing our financial and operating results for the 3 months ended June 30, 2019. The press release is available on the News and Investors page of our website at recropharma.com.

Before we begin our formal comments, I'll remind you that various remarks we make today constitute

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot